Aseptuva
Develops far-UVC based photonic devices intended to reduce hospital-acquired infections (HAI) by preventing bacterial and fungal colonization of catheter entry sites. Activities include in‑vitro proof-of-concept testing, prototype design and fabrication, preclinical validation and clinical usability studies, intellectual property management, and regulatory/QMS development supported by multiple grant-funded collaborations.
Industries
Nr. of Employees
small (1-50)
Products
Far-UVC device prototypes for prevention of catheter-site colonization
Functional prototypes of far-UVC based devices designed to reduce bacterial and fungal colonization at catheter entry sites; used for preclinical validation and clinical usability studies.
Far-UVC device prototypes for prevention of catheter-site colonization
Functional prototypes of far-UVC based devices designed to reduce bacterial and fungal colonization at catheter entry sites; used for preclinical validation and clinical usability studies.
Services
Providing preclinical validation and usability studies of photonic disinfection prototypes in hospital settings.
Providing preclinical validation and usability studies of photonic disinfection prototypes in hospital settings.
Expertise Areas
- Hospital-acquired infection prevention
- Photonic/UV disinfection device development
- Preclinical and clinical usability evaluation
- Microbiological efficacy testing
Key Technologies
- Far-UVC disinfection
- Photonics and UVC/laser light sources
- In‑vitro microbiological assays
- Prototype CAD and mechanical prototyping
News & Updates
Closed a CHF 2.4 million seed round to advance far-UVC technology.
Developed an in-situ UV-based solution in collaboration with a laser research center, supported by PhotonHub Europe (Horizon 2020).
Awarded an NIHR i4i grant to conduct studies with hospitals, labs and packaging partners.
Awarded MedPhab Horizon 2020 grant for product development in collaboration with industrial research partners.
Completed usability study at a university hospital evaluating technology performance in clinical environments.
Awarded grant to test sustainable materials and manufacturing processes for product development.
Closed a CHF 2.4 million seed round to advance far-UVC technology.
Developed an in-situ UV-based solution in collaboration with a laser research center, supported by PhotonHub Europe (Horizon 2020).
Awarded an NIHR i4i grant to conduct studies with hospitals, labs and packaging partners.
Awarded MedPhab Horizon 2020 grant for product development in collaboration with industrial research partners.
Completed usability study at a university hospital evaluating technology performance in clinical environments.
Awarded grant to test sustainable materials and manufacturing processes for product development.